Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label followthru. Show all posts
Showing posts with label followthru. Show all posts

Sunday, June 7, 2020

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury

WHOM THE HELL do we go to to get this tested for stroke and in humans? I want SPECIFIC NAMES that will take responsibility for followthru.

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury




Highlights

•
Curcumin rescued spatial memory after TBI in rats.
•
Curcumin decreased TBI-induced chronic neuroinflammation.
•
Curcumin increased hippocampal neurogenesis after TBI.
•
Curcumin may regulate these changes via the BNDF/Trkb/PI3K/AKT pathway.

Abstract

Cognitive decline is one of the most obvious symptoms of traumatic brain injury (TBI). Previous studies have demonstrated that cognitive decline is related to substantially increased neuroinflammation and decreased neurogenesis in the hippocampus in a rat model of TBI. Using this model, we explored the role of curcumin (Cur) in ameliorating TBI-impaired spatial memory because Cur has been shown to exhibit anti-chronic-neuroinflammatory, neurogenesis-promoting, and memory-improving properties.
Animals received daily Cur or vehicle treatment for 28 days after TBI and also received 50-bromodeoxyuridine(BrdU) for the first 7 days of the treatment for assaying neurogenesis. An optimal Cur dose of 30 mg/kg, selected from a range of 10–50 mg/kg, was used for the present study. Neuroinflammation was evaluated by astrocyte hypertrophy, activated microglia, and inflammatory factors in the hippocampus. Behavioral water-maze studies were conducted for 5 days, starting at 35-day post-TBI. The tropomyosin receptor kinase B (Trkb) inhibitor, ANA-12, was used to test the role of the brain-derived neurotrophic factor (BDNF)/ TrkB/Phosphoinositide 3-kinase (PI3K)/Akt signaling pathway in regulating inflammation and neurogenesis in the hippocampus.
Treatment with Cur ameliorated the spatial memory of TBI rats, reduced TBI-induced chronic inflammation, typified by diminished astrocyte hypertrophy, reduction in activated microglia, declined inflammatory factors, and increased neurogenesis in the hippocampus. We also found that BDNF/Trkb/PI3K/Akt signaling was involved in the effects of Cur in TBI rats.
Thus, Cur treatment can ameliorate the spatial memory in a murine model of TBI, which may be attributable to decreased chronic neuroinflammation, increased hippocampal neurogenesis, and/or BDNF/Trkb/PI3K/Akt signaling.

Tuesday, January 29, 2019

Transcranial Direct Current Stimulation in Stroke Rehabilitation: Present and Future

Don't just lazily write that results have been inconclusive and future studies needed.  Make them conclusive. Isn't that what research is about? And you ARE A RESEARCHER? 

Which tDCS?

Transcranial Direct Current Stimulation in Stroke Rehabilitation: Present and Future


  • Oluwole O. AwosikaEmail author
  • Leonardo G. Cohen
  • Oluwole O. Awosika
    • 1
    • 2
    Email author
  • Leonardo G. Cohen
    • 1
  1. 1.Human Cortical Physiology and Stroke Neurorehabilitation SectionNational Institutes of HealthBethesdaUSA
  2. 2.Department of Neurology and Rehabilitation MedicineUniversity of Cincinnati College of MedicineCincinnatiUSA
Chapter

Abstract

Stroke is the leading cause of severe lasting adult disability around the world. Despite efforts to standardize post-stroke care and rehabilitation a significant percentage of patients remain permanently disabled. Life expectancy after stroke is on the rise in part due to improvements in health care. Hence, it is necessary to develop cost efficient ways to improve the beneficial effects of customary neurorehabilitative interventions (i.e., physical and occupational therapy) on motor and cognitive function after stroke. Over the years, transcranial direct current stimulation has emerged as a possible neuromodulatory tool adjuvant to standard neurorehabilitative therapy. Recent meta-analysis suggested moderate beneficial effects of tDCS on motor function after stroke. However, results from clinical trials have not been conclusive, suggesting the need to understand mechanisms underlying tDCS effects, including optimal stimulation protocols, timing, duration and magnitude of stimulation, and the identification of patient groups more amenable to tDCS effects. Here we discuss study results (organized by functional deficits) to date and discuss critically available evidence. Future studies could benefit from tighter experimental designs, more detailed description of methodologies, preregistration when appropriate and enhanced replication efforts.

Thursday, January 3, 2019

Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation

If salt is so bad then write up a diet protocol on it and get it distributed worldwide. Not doing so means you have no followthru and this writeup was worthless. 

Dietary salt promotes ischemic brain injury and is associated with parenchymal migrasome formation


Abstract

Sodium chloride promotes vascular fibrosis, arterial hypertension, pro-inflammatory immune cell polarization and endothelial dysfunction, all of which might influence outcomes following stroke. But despite enormous translational relevance, the functional importance of sodium chloride in the pathophysiology of acute ischemic stroke is still unclear. In the current study, we show that high-salt diet leads to significantly worse functional outcomes, increased infarct volumes, and a loss of astrocytes and cortical neurons in acute ischemic stroke. While analyzing the underlying pathologic processes, we identified the migrasome as a novel, sodium chloride-driven pathomechanism in acute ischemic stroke. The migrasome was previously described in vitro as a migrating organelle, which incorporates and dispatches cytosol of surrounding cells and plays a role in intercellular signaling, whereas a pathophysiological meaning has not been elaborated. We here confirm previously reported characteristics of the migrasome in vivo. Immunohistochemistry, electron microscopy and proteomic analyses further demonstrate that the migrasome incorporates and dispatches cytosol of surrounding neurons following stroke. The clinical relevance of these findings is emphasized by neuropathological examinations, which detected migrasome formation in infarcted brain parenchyma of human stroke patients. In summary, we demonstrate that high-salt diet aggravates stroke outcomes, and we characterize the migrasome as a novel mechanism in acute stroke pathophysiology.
PMID:
30589884
DOI:
10.1371/journal.pone.0209871
Free full text